These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9255101)

  • 41. The comparative effect on bone density, endometrium, and lipids of continuous hormones as replacement therapy (CHART study). A randomized controlled trial.
    Speroff L; Rowan J; Symons J; Genant H; Wilborn W
    JAMA; 1996 Nov; 276(17):1397-403. PubMed ID: 8892714
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Failure of estrogen plus progestin therapy for prevention.
    Fletcher SW; Colditz GA
    JAMA; 2002 Jul; 288(3):366-8. PubMed ID: 12117403
    [No Abstract]   [Full Text] [Related]  

  • 43. Hormone replacement therapy, hormone levels, and lipoprotein cholesterol concentrations in elderly women.
    Paganini-Hill A; Dworsky R; Krauss RM
    Am J Obstet Gynecol; 1996 Mar; 174(3):897-902. PubMed ID: 8633665
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Menopausal bone loss in long-term users of depot medroxyprogesterone acetate contraception.
    Cundy T; Cornish J; Roberts H; Reid IR
    Am J Obstet Gynecol; 2002 May; 186(5):978-83. PubMed ID: 12015524
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Natural progesterone, but not medroxyprogesterone acetate, enhances the beneficial effect of estrogen on exercise-induced myocardial ischemia in postmenopausal women.
    Rosano GM; Webb CM; Chierchia S; Morgani GL; Gabraele M; Sarrel PM; de Ziegler D; Collins P
    J Am Coll Cardiol; 2000 Dec; 36(7):2154-9. PubMed ID: 11127455
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. Early Postmenopausal Intervention Cohort Study Group.
    Hosking D; Chilvers CE; Christiansen C; Ravn P; Wasnich R; Ross P; McClung M; Balske A; Thompson D; Daley M; Yates AJ
    N Engl J Med; 1998 Feb; 338(8):485-92. PubMed ID: 9443925
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The heart and estrogen/progestin replacement study (HERS).
    Speroff L
    Maturitas; 1998 Nov; 31(1):9-14. PubMed ID: 10091199
    [No Abstract]   [Full Text] [Related]  

  • 48. Hormone replacement therapy causes a respiratory alkalosis in normal postmenopausal women.
    Orr-Walker BJ; Horne AM; Evans MC; Grey AB; Murray MA; McNeil AR; Reid IR
    J Clin Endocrinol Metab; 1999 Jun; 84(6):1997-2001. PubMed ID: 10372700
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-term continuous combined hormone replacement therapy in the prevention of postmenopausal bone loss: a comparison of high- and low-dose estrogen-progestin regimens.
    Heikkinen J; Vaheri R; Kainulainen P; Timonen U
    Osteoporos Int; 2000; 11(11):929-37. PubMed ID: 11193245
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Add-back therapy in the treatment of endometriosis: the North American experience.
    Moghissi KS
    Br J Obstet Gynaecol; 1996 Oct; 103 Suppl 14():14. PubMed ID: 8916981
    [No Abstract]   [Full Text] [Related]  

  • 51. The effect of estrogen plus progestin on knee symptoms and related disability in postmenopausal women: The Heart and Estrogen/Progestin Replacement Study, a randomized, double-blind, placebo-controlled trial.
    Nevitt MC; Felson DT; Williams EN; Grady D
    Arthritis Rheum; 2001 Apr; 44(4):811-8. PubMed ID: 11315920
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of medroxyprogesterone acetate and heparin in the prevention of postsurgical adhesion formation in the rat uterine model.
    Sağol S; Ozşener S; Dinçer O; Yilmaz H; Karadadas N
    J Obstet Gynaecol Res; 1999 Aug; 25(4):287-93. PubMed ID: 10540534
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Raloxifene versus continuous combined estrogen/progestin therapy: densitometric and biochemical effects in healthy postmenopausal Taiwanese women.
    Tsai KS; Yen ML; Pan HA; Wu MH; Cheng WC; Hsu SH; Yen BL; Huang KE
    Osteoporos Int; 2001 Dec; 12(12):1020-5. PubMed ID: 11846327
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of combination estrogen plus progestin hormone treatment on cognition and affect.
    Resnick SM; Maki PM; Rapp SR; Espeland MA; Brunner R; Coker LH; Granek IA; Hogan P; Ockene JK; Shumaker SA;
    J Clin Endocrinol Metab; 2006 May; 91(5):1802-10. PubMed ID: 16522699
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Exercise-associated amenorrhea, low bone density, and estrogen replacement therapy.
    Cumming DC
    Arch Intern Med; 1996 Oct; 156(19):2193-5. PubMed ID: 8885817
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of low-dose continuous combined conjugated estrogens and medroxyprogesterone acetate on menopausal symptoms, body weight, bone density, and metabolism in postmenopausal women.
    Gambacciani M; Ciaponi M; Cappagli B; Genazzani AR
    Am J Obstet Gynecol; 2001 Nov; 185(5):1180-5. PubMed ID: 11717654
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Health symptom-free women do not need preventive hormone replacement therapy. The risks outweigh the benefits; a large trial prematurely interrupted in the USA].
    von Schoultz B
    Lakartidningen; 2002 Aug; 99(34):3276-8. PubMed ID: 12362844
    [No Abstract]   [Full Text] [Related]  

  • 58. [A mammographic evaluation of the morphostructural variations of the breast during hormone-replacement therapy in the postmenopause].
    Porfiri LM; Costanza L; De Felice C; Perrone G; David V; Zichella L
    Radiol Med; 1998 Jun; 95(6):573-6. PubMed ID: 9717537
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Estrogen plus progestin and the risk of coronary heart disease.
    Manson JE; Hsia J; Johnson KC; Rossouw JE; Assaf AR; Lasser NL; Trevisan M; Black HR; Heckbert SR; Detrano R; Strickland OL; Wong ND; Crouse JR; Stein E; Cushman M;
    N Engl J Med; 2003 Aug; 349(6):523-34. PubMed ID: 12904517
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Autonomic and cardiovascular function in postmenopausal women: the effects of estrogen versus combination therapy.
    Farag NH; Nelesen RA; Parry BL; Loredo JS; Dimsdale JE; Mills PJ
    Am J Obstet Gynecol; 2002 May; 186(5):954-61. PubMed ID: 12015521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.